First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.

Br J Cancer · 1998 · PMC2063206 · PMID 9836480

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

splatin control group in this trial. What about GOG-1 32? The statistical explanations False-positive results in GOG- 111 and the Intergroup trial Did the difference between the two arms in the Intergroup trial and GOG- 111 arise purely by chance? The results of both of these trials are highly significant for both progression-free and overall survival, and the results of both trials are very similar.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.